Paloma Partners Management CO Selecta Biosciences Inc Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$1.32 - $2.47 $124,854 - $233,629
-94,587 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$1.6 - $2.08 $94,900 - $123,371
-59,313 Reduced 38.54%
94,587 $166,000
Q2 2019

Aug 14, 2019
BUY
$1.79 - $3.05 $275,481 - $469,395
153,900 New
153,900 $275,000

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email